BackOriginal BioMedicals , Ltd. Overview

Original BioMedicals , Ltd. Intangible Assets

Track Original BioMedicals , Ltd.'s intangible assets ($480K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$477000.00

Peer trimmed avg / median

Loading

Original BioMedicals , Ltd. Intangible Assets History

Loading

Original BioMedicals , Ltd. vs. peers: Intangible Assets Comparison

Loading

Original BioMedicals , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Original BioMedicals , Ltd. (6483.TWO) FAQ

Original BioMedicals , Ltd. (6483.TWO) currently reports a intangible assets of $480K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Original BioMedicals , Ltd.'s intangible assets history and peer comparisons.

Original BioMedicals , Ltd.'s intangible assets changed from $0 to $480K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Original BioMedicals , Ltd. reported $480K in intangible assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $480K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Original BioMedicals , Ltd., and consider following 6483.TWO for alerts when major investors trade the stock.